Clinical trial
Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic…
NCT00051688 · Chiron Corporation, Industry · Terminated
Key facts
| NCT number | NCT00051688 |
|---|---|
| Title | Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer |
| Lead sponsor | Chiron Corporation, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms |
| Intervention type | Drug |
| Interventions | tezacitabine, oxaliplatin |
| Start date | Jun 1, 2003 |
| Completion | Aug 1, 2004 |
| First posted | Jan 16, 2003 |
| Last update posted | Jul 11, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: